N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole

C119H171N25O14P2S2 — CID 160803549

IUPACN-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole
SMILESCC(C)(C)c1coc(-n2ccnc2)n1.CC(C)(C)c1nc(-c2cccc(P(C)(C)=O)c2)no1.CC(C)(C)c1nc(-n2cnc(S(=O)(=O)N3CCOCC3)c2)no1.CC(C)(C)c1ncc(NCc2ccccc2)o1.CC(C)(C)c1nnc(CCc2ccccc2)o1.CC(C)(C)c1nnc(CN2CCC(N)CC2)o1.CC(C)(C)c1nnc(CSc2ccccc2)o1.CC(c1nc(C(C)(C)C)no1)N1CCNCC1.CCP(=O)(CC)c1cccc(-c2ncc(C(C)(C)C)o2)c1
InChIInChI=1S/C17H24NO2P.C14H19N2O2P.2C14H18N2O.C13H19N5O4S.C13H16N2OS.2C12H22N4O.C10H13N3O/c1-6-21(19,7-2)14-10-8-9-13(11-14)16-18-12-15(20-16)17(3,4)5;1-14(2,3)13-15-12(16-18-13)10-7-6-8-11(9-10)19(4,5)17;1-14(2,3)13-16-10-12(17-13)15-9-11-7-5-4-6-8-11;1-14(2,3)13-16-15-12(17-13)10-9-11-7-5-4-6-8-11;1-13(2,3)11-15-12(16-22-11)17-8-10(14-9-17)23(19,20)18-4-6-21-7-5-18;1-13(2,3)12-15-14-11(16-12)9-17-10-7-5-4-6-8-10;1-9(16-7-5-13-6-8-16)10-14-11(15-17-10)12(2,3)4;1-12(2,3)11-15-14-10(17-11)8-16-6-4-9(13)5-7-16;1-10(2,3)8-6-14-9(12-8)13-5-4-11-7-13/h8-12H,6-7H2,1-5H3;6-9H,1-5H3;4-8,10,15H,9H2,1-3H3;4-8H,9-10H2,1-3H3;8-9H,4-7H2,1-3H3;4-8H,9H2,1-3H3;9,13H,5-8H2,1-4H3;9H,4-8,13H2,1-3H3;4-7H,1-3H3
InChIKeySDJWQUQOPLXSCE-UHFFFAOYSA-N
MW2301.92 g/mol
LogP23.70
Rot. Bonds23

About N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole

N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole (PubChem CID 160803549) has the molecular formula C119H171N25O14P2S2 and a molecular weight of 2301.92 g/mol. Its IUPAC name is N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole.

Molecular Properties

Compound NameN-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole
PubChem CID160803549
Molecular FormulaC119H171N25O14P2S2
Molecular Weight2301.92 g/mol
Exact Mass2300.24
IUPAC NameN-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole
SMILESCC(C)(C)c1coc(-n2ccnc2)n1.CC(C)(C)c1nc(-c2cccc(P(C)(C)=O)c2)no1.CC(C)(C)c1nc(-n2cnc(S(=O)(=O)N3CCOCC3)c2)no1.CC(C)(C)c1ncc(NCc2ccccc2)o1.CC(C)(C)c1nnc(CCc2ccccc2)o1.CC(C)(C)c1nnc(CN2CCC(N)CC2)o1.CC(C)(C)c1nnc(CSc2ccccc2)o1.CC(c1nc(C(C)(C)C)no1)N1CCNCC1.CCP(=O)(CC)c1cccc(-c2ncc(C(C)(C)C)o2)c1
InChIInChI=1S/C17H24NO2P.C14H19N2O2P.2C14H18N2O.C13H19N5O4S.C13H16N2OS.2C12H22N4O.C10H13N3O/c1-6-21(19,7-2)14-10-8-9-13(11-14)16-18-12-15(20-16)17(3,4)5;1-14(2,3)13-15-12(16-18-13)10-7-6-8-11(9-10)19(4,5)17;1-14(2,3)13-16-10-12(17-13)15-9-11-7-5-4-6-8-11;1-14(2,3)13-16-15-12(17-13)10-9-11-7-5-4-6-8-11;1-13(2,3)11-15-12(16-22-11)17-8-10(14-9-17)23(19,20)18-4-6-21-7-5-18;1-13(2,3)12-15-14-11(16-12)9-17-10-7-5-4-6-8-10;1-9(16-7-5-13-6-8-16)10-14-11(15-17-10)12(2,3)4;1-12(2,3)11-15-14-10(17-11)8-16-6-4-9(13)5-7-16;1-10(2,3)8-6-14-9(12-8)13-5-4-11-7-13/h8-12H,6-7H2,1-5H3;6-9H,1-5H3;4-8,10,15H,9H2,1-3H3;4-8H,9-10H2,1-3H3;8-9H,4-7H2,1-3H3;4-8H,9H2,1-3H3;9,13H,5-8H2,1-4H3;9H,4-8,13H2,1-3H3;4-7H,1-3H3
InChIKeySDJWQUQOPLXSCE-UHFFFAOYSA-N
XLogP23.70
TPSA484.56 Ų
H-Bond Donors3
H-Bond Acceptors39
Rotatable Bonds23
Heavy Atoms162
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002301.92
LogP ≤ 523.70
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;(2-tert-butyl-1,3-oxazol-4-yl)methanamine;[3-(4-tert-butyl-1,3-oxazol-2-yl)phenyl]-piperazin-1-ylmethanone;(5-tert-butyl-1,3-oxazol-2-yl)-pyrrolidin-1-ylmethanone;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;5-tert-butyl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole
CID 158195440
N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;5-tert-butyl-3-methyl-1,2,4-oxadiazole;(2-tert-butyl-1,3-oxazol-4-yl)methanamine;[3-(4-tert-butyl-1,3-oxazol-2-yl)phenyl]-piperazin-1-ylmethanone;(5-tert-butyl-1,3-oxazol-2-yl)-pyrrolidin-1-ylmethanone;2-tert-butyl-5-phenyl-1,3,4-oxadiazole;5-tert-butyl-3-phenyl-1,2-oxazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;5-tert-butyl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole
CID 159603672
N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;(2-tert-butyl-1,3-oxazol-4-yl)methanamine;(5-tert-butyl-1,3-oxazol-2-yl)-pyrrolidin-1-ylmethanone;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;3-tert-butyl-5-phenyl-1,2,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole;3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;1-(1,3,4-oxadiazol-2-ylmethyl)piperidin-4-amine
CID 157612353
5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;N-(3-tert-butyl-1,2,4-oxadiazol-5-yl)benzamide;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;4-(3-tert-butyl-1,2,4-oxadiazol-5-yl)morpholine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-pyrrolidin-2-ylpropan-1-one;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;3-tert-butyl-5-phenyl-1,2,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole;5-tert-butyl-3-(piperazin-1-ylmethyl)-1,2,4-oxadiazole;3-tert-butyl-5-(pyrazol-1-ylmethyl)-1,2,4-oxadiazole
CID 159427271
N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;(2-tert-butyl-1,3-oxazol-4-yl)methanamine;(5-tert-butyl-1,3-oxazol-2-yl)-pyrrolidin-1-ylmethanone;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole
CID 159786385
N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole
CID 160035696
5-Tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;3-tert-butyl-5-phenyl-1,2,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole;3-tert-butyl-5-(pyrazol-1-ylmethyl)-1,2,4-oxadiazole
CID 160864025
N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;3-tert-butyl-5-phenyl-1,2,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole
CID 161020857

Frequently Asked Questions

What is the IUPAC name of N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole?
The IUPAC name of N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole (CID 160803549) is N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole.
What is the SMILES notation for N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole?
The canonical SMILES for N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole is CC(C)(C)c1coc(-n2ccnc2)n1.CC(C)(C)c1nc(-c2cccc(P(C)(C)=O)c2)no1.CC(C)(C)c1nc(-n2cnc(S(=O)(=O)N3CCOCC3)c2)no1.CC(C)(C)c1ncc(NCc2ccccc2)o1.CC(C)(C)c1nnc(CCc2ccccc2)o1.CC(C)(C)c1nnc(CN2CCC(N)CC2)o1.CC(C)(C)c1nnc(CSc2ccccc2)o1.CC(c1nc(C(C)(C)C)no1)N1CCNCC1.CCP(=O)(CC)c1cccc(-c2ncc(C(C)(C)C)o2)c1.
What is the InChIKey of N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole?
The InChIKey is SDJWQUQOPLXSCE-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H24NO2P.C14H19N2O2P.2C14H18N2O.C13H19N5O4S.C13H16N2OS.2C12H22N4O.C10H13N3O/c1-6-21(19,7-2)14-10-8-9-13(11-14)16-18-12-15(20-16)17(3,4)5;1-14(2,3)13-15-12(16-18-13)10-7-6-8-11(9-10)19(4,5)17;1-14(2,3)13-16-10-12(17-13)15-9-11-7-5-4-6-8-11;1-14(2,3)13-16-15-12(17-13)10-9-11-7-5-4-6-8-11;1-13(2,3)11-15-12(16-22-11)17-8-10(14-9-17)23(19,20)18-4-6-21-7-5-18;1-13(2,3)12-15-14-11(16-12)9-17-10-7-5-4-6-8-10;1-9(16-7-5-13-6-8-16)10-14-11(15-17-10)12(2,3)4;1-12(2,3)11-15-14-10(17-11)8-16-6-4-9(13)5-7-16;1-10(2,3)8-6-14-9(12-8)13-5-4-11-7-13/h8-12H,6-7H2,1-5H3;6-9H,1-5H3;4-8,10,15H,9H2,1-3H3;4-8H,9-10H2,1-3H3;8-9H,4-7H2,1-3H3;4-8H,9H2,1-3H3;9,13H,5-8H2,1-4H3;9H,4-8,13H2,1-3H3;4-7H,1-3H3.
What are the key properties of N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole?
N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole has a molecular weight of 2301.92 g/mol, XLogP of 23.70, 23 rotatable bonds, 3 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for N-benzyl-2-tert-butyl-1,3-oxazol-5-amine;5-tert-butyl-2-(3-diethylphosphorylphenyl)-1,3-oxazole;5-tert-butyl-3-(3-dimethylphosphorylphenyl)-1,2,4-oxadiazole;4-tert-butyl-2-imidazol-1-yl-1,3-oxazole;4-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)imidazol-4-yl]sulfonylmorpholine;1-[(5-tert-butyl-1,3,4-oxadiazol-2-yl)methyl]piperidin-4-amine;2-tert-butyl-5-(2-phenylethyl)-1,3,4-oxadiazole;2-tert-butyl-5-(phenylsulfanylmethyl)-1,3,4-oxadiazole;3-tert-butyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole is sourced from PubChem (CID 160803549), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).